Alacrita and Inc Research hosting thought leadership luncheon on Thursday November 3

Alacrita and INC Research are co-hosting a thought leadership luncheon on Thursday, November 3rd at the Le Meriden Hotel in Cambridge, MA from 11:00-1:30pm for biotech/pharma companies specializing in hematology and oncology.

The lunch will feature remarks from Scott Jackson, former CEO of Celator Pharma, who will tell his story of re-formulating a compound for the treatment of AML and his partnering journey with Jazz Pharma.

The event will also include three round table discussions on the following topics:

  • Seamless Designs
  • Impact of Novel Developments (including Immuno -Oncology) on Investigators and Trial Participation
  • “Novel” Geographies to Consider for Biotech Phase I/II Oncology Clinical Trials

Register Here

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Stay in touch